Clinical Trial Update: Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an ethanol-gelfoam mixture to treat arterioportal shunts in hepatocellular carcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ethanol-gelfoam mixture (ethanol-gelfoam mixture)

Snippet

Sponsor: Nanjing Medical University | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: UNKNOWN